| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.93M | - | |
| VP | 141.5K | $11.29M | - | |
| Other | 87.3K | $6.96M | - | |
| VP | 73.6K | $5.87M | -15,000 | |
| CFO | 70.1K | $5.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $47.86 | $478,600.00 | -2.4% | -9.3% | -30.3% | |
| Oct 13, 2022 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 21,513 | $47.28 | $1,017,134.64 | -11.3% | -15.2% | -29.7% | |
| Oct 3, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $50.40 | $504,000.00 | -2.4% | -13.2% | -47.4% | |
| Sep 19, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $51.42 | $514,200.00 | -2.4% | -15.8% | -37.0% | |
| Sep 12, 2022 | Henderson John T65 | Director | Sale+OE | 21,759 | $54.94 | $1,195,548.22 | -23.2% | -29.6% | -35.6% | |
| Sep 8, 2022 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 21,500 | $51.88 | $1,115,420.00 | -11.3% | -31.5% | -33.3% | |
| Sep 7, 2022 | Blum Robert I51 | President &CEO | Sale+OE | 10,000 | $49.11 | $491,100.00 | -2.4% | -27.4% | -28.2% | |
| Sep 2, 2022 | Smith Sandford D48 | Director | Sale+OE | 11,369 | $53.97 | $613,584.93 | -48.3% | -24.4% | -33.4% | |
| Sep 1, 2022 | Parshall B Lynne74 | Director | Sale+OE | 30,296 | $52.79 | $1,599,325.84 | -75.2% | -20.9% | -33.0% | |
| Sep 1, 2022 | Costa Santo J | Director | Sale+OE | 15,000 | $52.79 | $791,850.00 | -60.0% | -20.9% | -33.0% |